m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer.

[1]  R. Ferris,et al.  Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment , 2022, Nature Reviews Cancer.

[2]  Zhen Liu,et al.  Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells , 2022, Bioengineered.

[3]  Fan Wang,et al.  A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p , 2022, Journal of experimental & clinical cancer research : CR.

[4]  Xiaoyu Chen,et al.  METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis , 2022, Molecular cancer.

[5]  Xianqun Fan,et al.  The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation , 2022, Oncogene.

[6]  T. Tsukamoto,et al.  Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells , 2022, Journal for ImmunoTherapy of Cancer.

[7]  Xiaoyu Chen,et al.  Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling , 2021, Frontiers in Oncology.

[8]  K. Yeoh,et al.  Mapping the genomic diaspora of gastric cancer , 2021, Nature Reviews Cancer.

[9]  Jianjie Li,et al.  miR-181a-2-3p Stimulates Gastric Cancer Progression via Targeting MYLK , 2021, Frontiers in Bioengineering and Biotechnology.

[10]  Peng Zhang,et al.  FGF14-AS2 accelerates tumorigenesis in glioma by forming a feedback loop with miR-320a/E2F1 axis , 2021, Journal of Cancer.

[11]  F. Aires-da-Silva,et al.  Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy , 2021, International journal of molecular sciences.

[12]  K. Fisher,et al.  Deregulation of HLA-I in cancer and its central importance for immunotherapy , 2021, Journal for ImmunoTherapy of Cancer.

[13]  Peng Xu,et al.  CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6 , 2021, Gastric Cancer.

[14]  Qitai Zhao,et al.  Immune infiltration profiling in gastric cancer and their clinical implications , 2021, Cancer science.

[15]  Bingxin Chen,et al.  Chinese and global burdens of gastric cancer from 1990 to 2019 , 2021, Cancer medicine.

[16]  Cuiping Yang,et al.  The role of m6A modification in the biological functions and diseases , 2021, Signal Transduction and Targeted Therapy.

[17]  B. Badgwell,et al.  Current treatment and recent progress in gastric cancer , 2021, CA: a cancer journal for clinicians.

[18]  J. Huse,et al.  YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. , 2020, Cancer cell.

[19]  A. Goodman,et al.  The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. , 2020, Cancer cell.

[20]  Xiaoyu Chen,et al.  Novel insights into the interplay between m6A modification and noncoding RNAs in cancer , 2020, Molecular Cancer.

[21]  H. Grabsch,et al.  Gastric cancer , 2020, The Lancet.

[22]  Chaochun Wei,et al.  Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells , 2020, Frontiers in Pharmacology.

[23]  C. Cho,et al.  m6A RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer , 2020, Theranostics.

[24]  Samie R. Jaffrey,et al.  A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA , 2020, Cell.

[25]  Amber M. Johnson,et al.  Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms , 2020, Journal for ImmunoTherapy of Cancer.

[26]  B. Zhang,et al.  m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer , 2020, Molecular Cancer.

[27]  Jianjun Chen,et al.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. , 2020, Cancer cell.

[28]  Su Yao,et al.  Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3 , 2019, Molecular Cancer.

[29]  S. Cai,et al.  Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer , 2019, Cancer Immunology Research.

[30]  Beibei Ru,et al.  TISIDB: an integrated repository portal for tumor-immune system interactions , 2019, Bioinform..

[31]  Samie R Jaffrey,et al.  Reading, writing and erasing mRNA methylation , 2019, Nature Reviews Molecular Cell Biology.

[32]  Xiaoyu Chen,et al.  The role of m6A RNA methylation in human cancer , 2019, Molecular cancer.

[33]  K. Fung,et al.  A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis , 2019, Clinical Cancer Research.

[34]  F. López-Ríos,et al.  Implementing TMB measurement in clinical practice: considerations on assay requirements , 2019, ESMO Open.

[35]  Qiong Zhang,et al.  GSCALite: a web server for gene set cancer analysis , 2018, Bioinform..

[36]  Tim Hui-Ming Huang,et al.  Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression , 2018, Science Advances.

[37]  T. Schumacher,et al.  Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.

[38]  R. Bourgon,et al.  TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.

[39]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[40]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[41]  Yuval Kluger,et al.  m6A mRNA methylation controls T cell homeostasis by targeting IL-7/STAT5/SOCS pathway , 2017, Nature.

[42]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.

[43]  Yun-Gui Yang,et al.  Cytoplasmic m6A reader YTHDF3 promotes mRNA translation , 2017, Cell Research.

[44]  Chuan He,et al.  YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA , 2017, Cell Research.

[45]  A. Lánczky,et al.  miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients , 2016, Breast Cancer Research and Treatment.

[46]  L. Zitvogel,et al.  Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  E. Wherry,et al.  Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling , 2016, Cell.

[48]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[49]  Samir Adhikari,et al.  Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase , 2014, Cell Research.

[50]  Miao Yu,et al.  A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.

[51]  Min Deng,et al.  miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression , 2013, Clinical Cancer Research.

[52]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[53]  H. Aburatani,et al.  Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.

[54]  G. Giles,et al.  Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers , 2010, Proceedings of the National Academy of Sciences.

[55]  Anestis Antoniadis,et al.  Statistical Applications in Genetics and Molecular Biology Lasso Logistic Regression , GSoft and the Cyclic Coordinate Descent Algorithm : Application to Gene Expression Data , 2011 .

[56]  Bo Liu,et al.  Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[57]  V. Narry Kim,et al.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.

[58]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[59]  Lieping Chen,et al.  Interferon regulatory factor‐1 is prerequisite to the constitutive expression and IFN‐γ‐induced upregulation of B7‐H1 (CD274) , 2006, FEBS letters.

[60]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[62]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.